Journal
INTERNATIONAL JOURNAL OF OBESITY
Volume 39, Issue 1, Pages 82-84Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ijo.2014.59
Keywords
healthy aging; reverse causation; obesity epidemic; survival advantage; body mass index
Categories
Funding
- Allergan Inc
- Metagenics
- iNova Pharmaceuticals
- Medtronic
- Servier Australia
- Abbott
- Allergan Inc.
- Pfizer
- Wyeth Pharmaceuticals
- Servier
Ask authors/readers for more resources
The 'obesity paradox' refers to observations that run counter to the thesis that normal weight (BMI 18.5-24.9 kg/m(2)) provides the lowest mortality and higher weight is associated with greater mortality. We argue that the weight of lowest mortality is influenced by aging and chronic disease, with mortality advantage extending into the overweight and even class I obese ranges under some circumstances. A focus on quality nutrition, physical activity, fitness, and maintaining function in these weight ranges may be preferable to a focus on intentional weight loss, which has uncertain effects. The 'obesity paradox' is no 'paradox' if one defines and interprets 'ideal' weight appropriately.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available